Determination of total and free mycophenolic acid and its glucuronide in human plasma by HPLC with postcolumn derivatization

Zheng JIAO,Jie SHEN,Ming ZHANG,Yan ZHONG,Jian-yong ZHONG,Zhi-wei GAO,Ming-kang ZHONG,Yun-qiu YU

DOI: https://doi.org/10.3321/j.issn:1001-2494.2005.17.018

2005-01-01

Abstract:OBJECTIVE: To establish a HPLC method for determining total and free concentration of mycophenolic acid (MPA) and its glucuronide (MPAG) in human plasma. METHODS: Plasma samples were treated by ultra-filtration and protein precipitation for the determination of free and total analytes, respectively. Kromasil C8(4.6 mm × 150 mm, 5 μm) was used as the analytical column and maintained at 30 °C . The mobile phase consisted of a mixture of methanol: 0.1% trifluoroacetic acid (55:45, pH 2.2) at a flow rate of 1.2 mL·min-1. Regarding to the postcolumn derivatization, the other HPLC pump was added to deliver 0.2 mol·L-1 NaOH at a flow rate of 0.2 mL·min-1. MPAG was determined by UV absorbance and the detection wavelength was set at 295 nm while MPA was measured by fluorescence detection with λex 342 nm and λem, 425 nm. RESULTS: The endogenous interference and commonly co-medicated medicine did not interfere with the analytes determination. The alibration curves of total MPA and MPAG were in the ranges of 0.1-40 and 10-250 mg·L-1, as well as free MPA and MPAG of 0.01-1.0 and 2.5-100 mg·L-1, respectively. The RSDs of within-run and between-run were less than 10%. The samples were stable for 24 h after being processed at room temperature and the three-cycle of freezing and thawing test. CONCLUSION: The current established method can be used to determine the concentrations of total and free MPA and MPAG in human plasma and it can also be applied to the clinical pharmacy research and routine therapeutic drug monitoring.